Each month, Beauhurst issues a briefing on the most interesting UK startup deals from the previous month; in this case, May 2017. It is covered by various news publications and subsequently published here.
If you'd like to join the distribution list or write about the data, do get in touch at email@example.com: we're happy to take specific requests, and always open to new partnerships. We just ask for a credit and link back to about.beauhurst.com.
Number of deals: 202
Total raised: £941m
Average deal size: £4.95m
Average pre-money valuation: £8.25m
May saw an unusually high amount invested (up £351m from April's £590m) in high-growth companies. This was due almost exclusively to Improbable's huge raise – the largest amount raised by a UK company since Beauhurst's records began, seven years ago.
Deal numbers, however, continued their steep decline from April, plummeting to 202 from 379 in April and 470 in March. Slightly lower numbers than the previous month are always to be expected, given that companies which closed rounds at the end of May still have a week in which to file the deal, but the scale of this drop and its continuation from April suggests other factors at issue; uncertainty surrounding the General Election might play a role.
There were 322 deals this time last year, and it is unlikely that we will see the shortfall made up in the coming two weeks. That said, every May since 2010 has seen a deal dropoff (frequently large) from the preceding April – possibly related to the financial year's end.
Crowdcube participated in the most fundraisings (4) this May of any funder, followed jointly by Accelerated Digital Ventures, Mercia Fund Management, Seedrs, and Woodford Investment Management.
Improbable is developing technology that facilitates the creation of simulated worlds – software that simulates the behaviours of a large number of entities within a given environment. This has applications for gaming, defence, energy, transportation, health and finance.
Deal date: 11th May 2017
Deal amount: $502 (£389)
Investors: SoftBank Capital
4. MiNA Therapeutics
Deal date: 3rd May 2017
Try Beauhurst for free
The Beauhurst platform helps professionals discover, track and target the most ambitious companies in the UK.